Abstract:OBJECTIVE:To prospectively study clinical features and etiology in patients with incident Budd-Chiari syndrome (BCS) in China.METHODS:Taking consecutive case series of patients with incident BCS as who were diagnosed in our hospital, enrolled from September 2010 to January 2012 as the object of research, and the follow-up was lasting until June 2012. Taking records for all patients' symptoms, signs, laboratory findings, radiology findings, treatment, interventional treatment survival and symptom-free period.RESULTS:There are total 149 incident cases of BCS. In which, the median age was 46 years old (range 10 to 82); 61.7% of them were male patients, 38.3% were female patients; 85.9% of them were chronic, the other patients (14.1%) were diagnosed during acute or subacute periods; the median duration of symptoms before diagnosis was 96 months (range 1 day to 360 months). In terms of causes, 30.9% of the patients caused by hepatic venous block, 5.4% of them resulted from inferior vena cava block, and the rest 63.8% were suffered from combined hepatic venous and inferior vena cava block. 80.5% patients have at least one etiological factor, Furthermore, the most common cause was the web (61.1%), only 4.8% have myeloproliferative diseases (JAK2 V617F mutation), and none Factor V Leiden mutation cases was found. 144 patients were treated by percutaneous transluminal angioplasty, the technical success rate was 95.1%, and took oral anticoagulation therapy for 12 months. At 18 months, The survival rate and the symptom-free survival rate after percutaneous transluminal angioplasty were 97.8% and respectively.CONCLUSION:Web is the most prevalent etiological factor for BCS in China. It is different in western countries; the common reasons of BCS are risk factors related to thrombosis, such as myeloproliferative disease and Factor V Leiden mutation, etc., which are seldom found in Chinese BCS patients. In China, most chronic BCS patients were treated with percutaneous transluminal angioplasty and have excellent clinical outcome.

Intravenous Lymphatic Cyst in Inferior Vena Cava - A Rare Cause of Budd-Chiari Syndrome.

Myxoma Immediately above the Junction of the Inferior Vena Cava and the Right Atrium: A Rare Cause of Budd-Chiari Syndrome

Imaging findings of Budd-Chiari syndrome caused by intravenous leiomyomatosis: a case report

The Clinical Characteristics of 151 Cases of Budd-Chiari Syndrome

Atypical Budd-Chiari syndrome induced by rare collateral pathways: one-case analysis

Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review

S4263 Budd-Chiari Plus a Friend - A Case of Chronic Budd Chiari Syndrome and Simultaneous Superior Mesenteric Vein Thrombus

The diagnosis and treatment of Budd-Chiari syndrome with inferior vena cava thrombosis

Current Status of the Clinical Management of Budd-Chiari Syndrome

The Role of Intravascular Intervention in the Management of Budd-Chiari Syndrome

[Preliminary Study on Etiology of Budd-Chiari Syndrome Through Clinic and Experiment].

Study on Clinical Features and Etiology of Primary Budd-Chiari Syndrome

Budd-Chiari Syndrome Associated With Autoimmune Hemolytic Anemia, Immune Thrombocytopenic Purpura, and Lupus Nephritis: A Case Report

Rhabdoid meningioma with a history of Budd-Chiari syndrome: a case report and review of the literature

Radical Surgery under Genuine Direct Vision for the Treatment of Budd-Chiari Syndrome.

Intravascular interventional diagnosis and treatment of different types of Budd-Chiari syndrome (BCS)

S4275 Triple Risk Factors for Budd-Chiari Syndrome

Systemic Amyloidosis Presenting as Budd-Chiari Syndrome: A Case Report

Clinical Features and Etiology of Budd–Chiari Syndrome in Chinese Patients: A Single‐center Study

Interventional Treatment of Budd-Chiari Syndrome:Report of 312 Cases